mRNA vaccine technology moves to flu: Moderna says trial has begun

Moderna has given out the first doses of an mRNA-based influenza vaccine to participants in an early-phase clinical trial, the company announced Wednesday. Moderna ultimately plans to test the vaccine on about 180 people in the Phase 1/2 randomized, stratified, observer-blind trial. The trial will look at safety, different doses, and immune responses.
Read more: https://arstechnica.com/science/2021/07/mrna-vaccine-technology-moves-to-flu-moderna-says-trial-has-begun/?source=Snapzu